Print page Resize text Change font-size Change font-size Change font-size High contrast


Home > About Us > Steering group

ENCePP Steering Group

The ENCePP Steering Group was established in 2010 to oversee the mid to long-term implementation of the ENCePP project. The Steering Group consists of 16 members and provides a good balance of expertise (regulatory, conduct of pharmacoepidemiological studies, patients, healthcare professionals, ethical issues). Six members of the Steering Group are elected representatives from the ENCePP Plenary. From 2014 onwards the term of service of the Steering Group is three years.

The ENCePP Steering Group defines and safeguards the objectives and principles of ENCePP and decides on operational tasks of the network. The Steering Group is the highest authority of ENCePP and thus is its final decision making body. It acts as adjudicator in case of discrepancies or complaints in the context of the ENCePP network.

Related information:

» Mandate of the ENCePP Steering Group

» Steering Group meeting reports


 

Composition of the ENCePP Steering Group 2017-2019

 

 

printer-friendly version: Composition of ENCePP Steering Group 2017-2019

 

No. Representing Name Affiliation

1

ENCePP

Vera Ehrenstein

Department of Clinical Epidemiology, Aarhus University, Denmark

2

ENCePP

Rosa Gini

Agenzia regionale di sanità della Toscana, Florence, Italy

3

ENCePP

Teresa Herdeiro

iBiMED, University of Aveiro, Portugal

4

ENCePP

Olaf Klungel

Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Netherlands

5

ENCePP

Tom MacDonald

(Deputy Chair)

Medicines Monitoring Unit (MEMO) and Hypertension Research Centre (HRC), University of Dundee, UK

6

ENCePP

Gianluca Trifirò

University of Messina, Italy

7

EMA

Xavier Kurz

(Chair)

European Medicines Agency

8

EMA

Corinne de Vries

European Medicines Agency

9

EMA

Hans-Georg Eichler

European Medicines Agency

10

HMA

vacant

 

11
CHMP Johann Lodewijk Hillege College ter Beoordeling van Geneesmiddelen, Netherlands
12
COMP Dinah Duarte INFARMED - Autoridade Nacional do Medicamento e Produtos de Saúde, Portugal
13
PRAC Marieke de Bruin University of Copenhagen, Denmark
14
PCWP Kathi Apostolidis ECPC - European Cancer Patient Coalition
15
ISPE Yola Moride Faculty of Pharmacy, Université de Montréal, Canada
16
ISoP Herve Le Louet Centre de Pharmacovigilance & Information sur le médicament, Hôpital Henri Mondor, Paris, France
Observer EFPIA Patrice Verpillat Merck Group, Germany

Principal Scientific

Advisor

EMA Giampiero Mazzaglia European Medicines Agency

Statistical

Advisor

EMA Jim Slattery European Medicines Agency
Observer EMA Gianmario Candore European Medicines Agency

 

 

EMA European Medicines Agency
HMA Heads of Medicines Agencies
CHMP Committee for Medicinal Products for Human Use
COMP Committee for Orphan Medicinal Products
PRAC Pharmacovigilance Risk Assessment Committee
PCWP EMA Human Scientific Committees' Working Party with Patients' and Consumers' Organisations
ISPE International Society for Pharmacoepidemiology
ISoP International Society of Pharmacovigilance
EFPIA European Federation of Pharmaceutical Industries and Associations

 

 


Previous Steering Groups